Sequent Scientific Ltd. News and Updates

Name: Latest research reports of Sequent Scientific Ltd. authored by BP Wealth and published by - Trendlyne research reports.
Item: Sequent Scientific Ltd.
Rating: 3
Author: BP Wealth

Keep track of all breaking news on Sequent Scientific Ltd. from all sources in a single place.

Load latest

Sequent Scientific Ltd.

15 Jul 2021, 02:21PM

187.45

3.35%

Sequent Scientific up 9% on EUGMP nod for its tablets dosage form in Turkey

Business Standard

With over 120 product registrations, Sequent is the third-largest player in the Turkish ruminant market with a consolidated market share of around 10 per cent

Sequent Scientific Ltd. is trading below its 30 day SMA of 189.2

Sequent Scientific Ltd.

12 May 2021

187.45

3.35%

Reclusive Mankekar makes a splash with Solara stake

Economic Times

The Mumbai-based reclusive investor held nearly 4 per cent stake in Sequent Scientific till March 2018 and about 2.07 per cent in Strides Pharma till September 2017. This is Mankekar's first major investment since September 2019. Shareholding data showed he has not owned over 1 per cent in any company since then.

Sequent Scientific Ltd. is trading below its 30 day SMA of 189.2

Sequent Scientific Ltd.

26 Apr 2021

187.45

3.35%

Sequent Scientific (280.3): Buy

Business Line

Investors with a short-term perspective can buy the stock of Sequent Scientific at current levels. Since the stock took support at around 50 in March

Sequent Scientific Ltd. has gained 30.07% in the last 3 Months

Sequent Scientific Ltd.

05 Feb 2021

187.45

3.35%

BP Equities Sequent Scientific Ltd. Q3FY21 Result Update

Hold: Sequent Scientific Ltd.

Recommendation Target

BP Wealth

to 18.5% level, which was 111bps higher than our estimate driven by positive operating leverage. SSL Key Data reported a PAT of INR 372mn compared to our estimate of INR 302mn (23% above our estimate) led by operationally strong performance. Management maintained its revenue growth guidance of the mid -teen level. However, trimmed down margin growth guidance to 100bps (from earlier 200bps) YoY for the medium term due to remain competitive in the challenging pricing environment. The company...

Sequent Scientific Ltd. is trading above its 200 day SMA of 175.5

Sequent Scientific Ltd.

04 Feb 2021

187.45

3.35%

Sequent Scienti Consolidated December 2020 Net Sales at Rs 358.21 crore, up 13.21% Y-o-Y

Moneycontrol

NULL

Sequent Scientific Ltd. has gained 30.07% in the last 3 Months

Sequent Scienti Standalone December 2020 Net Sales at Rs 70.57 crore, up 14.2% Y-o-Y

Moneycontrol | 04 Feb 2021

Sequent Scientific Ltd.

03 Feb 2021

187.45

3.35%

SeQuent Scientific PAT up 65% at Rs 39.69 crore

Moneycontrol

Consolidated revenue from operations of the company stood at Rs 358.21 crore for the quarter under consideration.

Sequent Scientific Ltd. has gained 28.92% in the last 1 Year

Sequent Scientific Ltd.

16 Nov 2020, 04:36PM

187.45

3.35%

Street rewards all but one of 12 companies that pruned share pledges

Business Standard

Sequent Scientific and Everyday Industries saw percentage shareholding pledged by promoters go down by over 44 per cent each and their shares rally by 68 per cent and 75 per cent, respectively

Sequent Scientific Ltd. has gained 28.92% in the last 1 Year

Sequent Scientific Ltd.

09 Nov 2020

187.45

3.35%

BP Equities Sequent Scientific Ltd. Q2FY21 Result Update

Buy: Sequent Scientific Ltd.

BP Wealth

driven by positive operating leverage. During the quarter the company incurred one-time expenses of BSE code INR 90mn (onetime bonus and ESOPs of INR 52.1mn and INR 38.3mn related to discontinuation of Alivira France operations) under Exceptional item. SSL reported a PAT of INR 213mn compared to our estimate of INR 250mn. Adjusting onetime expenses, the Normalised PAT came in at INR297mn...

Sequent Scientific Ltd. has gained 28.92% in the last 1 Year

Sequent Scientific Ltd.

22 Sep 2020

187.45

3.35%

BP Equities Sequent Scientific Ltd. Initiating Coverage BUY Trgt 224

Buy: Sequent Scientific Ltd.

BP Wealth

Sequent Scientific Ltd. has gained 30.07% in the last 3 Months

Sequent Scientific Ltd.

11 Aug 2020

187.45

3.35%

Is it time to book profits in Sequent Scientific?

Moneycontrol

Carlyle Group's takeover of Sequent is expected to conclude in the current quarter. This ownership change is likely to help fast track the US business opportunity

Sequent Scientific Ltd. is trading above its 200 day SMA of 175.5

Is Sequent Scientific Ltd. worth buying?

315 Votes:

Buy 81.59%

Sell 11.11%

Hold 7.3%

59.74% Gain from 52W Low

Sequent Scientific Ltd. News and Updates

Keep track of all breaking news on Sequent Scientific Ltd. from all sources in a single place.